Class information for:
Level 2: ERYTHROPOIETIN//DARBEPOETIN ALFA//ANEMIA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
875 10801 37.0 76%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
397 27856 ERYTHROPOIETIN//ACUTE MOUNTAIN SICKNESS//HYPOXIA

Classes in level below (level 1)


ID, lev. below Publications Label for level below
1304 2627 ERYTHROPOIETIN//DARBEPOETIN ALFA//RENAL ANEMIA
4057 1781 ERYTHROPOIETIN//CELLULAR MOL CEREBRAL I EMIA//CARBAMYLATED ERYTHROPOIETIN
5322 1571 CHEMOTHERAPY INDUCED ANEMIA//EPOETIN ALFA//CHEMOTHERAPY INDUCED ANAEMIA
5530 1545 ANTIANEMIC AGENTS//CAS 11096 26 7//RECOMBINANT HUMAN ERYTHROPOIETIN RHEPO
7958 1232 ERYTHROPOIETIN RECEPTOR//STEM PROGENITOR CELL BIOL PROGRAM//ERYTHROBLAST MACROPHAGE PROTEIN
12067 870 BIOSIMILARS//BIOSIMILAR//ANTI ERYTHROPOIETIN ANTIBODIES
15749 625 CARDIORENAL ANEMIA SYNDROME//CONGEST HEART FAILURE UNIT//PL CARDIOVASC SYST
17164 550 POSTTRANSPLANT ERYTHROCYTOSIS//POST TRANSPLANT ERYTHROCYTOSIS//ERYTHROCYTOSIS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 ERYTHROPOIETIN Author keyword 1786 50% 24% 2612
2 DARBEPOETIN ALFA Author keyword 406 86% 2% 209
3 ANEMIA Author keyword 355 22% 13% 1458
4 ERYTHROPOIETIN RECEPTOR Author keyword 329 77% 2% 225
5 ERYTHROPOIESIS STIMULATING AGENTS Author keyword 253 77% 2% 174
6 EPOETIN Author keyword 218 74% 2% 163
7 EPOETIN BETA Author keyword 209 91% 1% 88
8 EPOETIN ALFA Author keyword 204 69% 2% 174
9 RECOMBINANT HUMAN ERYTHROPOIETIN Author keyword 183 56% 2% 225
10 ANAEMIA Author keyword 137 23% 5% 524

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 ERYTHROPOIETIN 1786 50% 24% 2612 Search ERYTHROPOIETIN Search ERYTHROPOIETIN
2 DARBEPOETIN ALFA 406 86% 2% 209 Search DARBEPOETIN+ALFA Search DARBEPOETIN+ALFA
3 ANEMIA 355 22% 13% 1458 Search ANEMIA Search ANEMIA
4 ERYTHROPOIETIN RECEPTOR 329 77% 2% 225 Search ERYTHROPOIETIN+RECEPTOR Search ERYTHROPOIETIN+RECEPTOR
5 ERYTHROPOIESIS STIMULATING AGENTS 253 77% 2% 174 Search ERYTHROPOIESIS+STIMULATING+AGENTS Search ERYTHROPOIESIS+STIMULATING+AGENTS
6 EPOETIN 218 74% 2% 163 Search EPOETIN Search EPOETIN
7 EPOETIN BETA 209 91% 1% 88 Search EPOETIN+BETA Search EPOETIN+BETA
8 EPOETIN ALFA 204 69% 2% 174 Search EPOETIN+ALFA Search EPOETIN+ALFA
9 RECOMBINANT HUMAN ERYTHROPOIETIN 183 56% 2% 225 Search RECOMBINANT+HUMAN+ERYTHROPOIETIN Search RECOMBINANT+HUMAN+ERYTHROPOIETIN
10 ANAEMIA 137 23% 5% 524 Search ANAEMIA Search ANAEMIA

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 RECOMBINANT HUMAN ERYTHROPOIETIN 1484 47% 22% 2373
2 EPOETIN ALPHA 731 65% 7% 704
3 DARBEPOETIN ALPHA 646 73% 5% 494
4 CHEMOTHERAPY INDUCED ANEMIA 306 80% 2% 192
5 SUBCUTANEOUS ERYTHROPOIETIN 302 80% 2% 185
6 COMMUNITY ONCOLOGY 268 72% 2% 209
7 ANEMIA 209 12% 15% 1655
8 EPOETIN 188 58% 2% 215
9 GLYCOL EPOETIN BETA 163 98% 0% 43
10 ANEMIA MANAGEMENT 149 71% 1% 122

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia 2008 347 47 96%
The non-haematopoietic biological effects of erythropoietin 2008 185 188 90%
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes 2010 93 80 90%
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease 2010 88 42 93%
ERYTHROPOIETIN - STRUCTURE, CONTROL OF PRODUCTION, AND FUNCTION 1992 768 473 79%
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update 2007 177 41 85%
ERYTHROPOIETIN 1991 931 122 73%
Traceability of biologicals: present challenges in pharmacovigilance 2015 5 20 30%
Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response 2008 152 189 82%
Emerging biological roles for erythropoietin in the nervous system 2005 265 99 86%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CELLULAR MOL CEREBRAL I EMIA 134 89% 0.6% 62
2 NEPHROL DIALYSIS RENAL TRANSPLANT 13 44% 0.2% 22
3 MULTIDISCIPLINAIRE ONCOL 10 50% 0.1% 14
4 HYPERTENS PREVENT NEPHROL 9 83% 0.0% 5
5 STEM PROGENITOR CELL BIOL PROGRAM 7 64% 0.1% 7
6 ADV LIFE MED SCI 6 80% 0.0% 4
7 P ONCOL UNIT PULMONOL 6 38% 0.1% 13
8 MOL MED GENET ENVIRONM HLTH SCI 6 71% 0.0% 5
9 AFDELING ONCOL HEMATOL 6 100% 0.0% 4
10 CHRON DIS GRP 5 16% 0.3% 30

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000014275 HIF 1 ALPHA//HYPOXIA INDUCIBLE FACTOR//HIF 1
2 0.0000010093 HEPCIDIN//HEMOCHROMATOSIS//IRON DEFICIENCY
3 0.0000009895 HEMODIALYSIS//BLOOD PURIFICATION//HAEMODIALYSIS
4 0.0000008794 ACUTE MOUNTAIN SICKNESS//HIGH ALTITUDE MEDICINE & BIOLOGY//HIGH ALTITUDE
5 0.0000008324 TRANSFUSION//VOX SANGUINIS//BLOOD TRANSFUSION
6 0.0000006938 EXPERIMENTAL HEMATOLOGY//G CSF//PLERIXAFOR
7 0.0000006430 THROMBOPOIETIN//ONCOSTATIN M//LEUKEMIA INHIBITORY FACTOR
8 0.0000005691 ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS
9 0.0000004888 RED CELL DISTRIBUTION WIDTH//MYCOPLASMA SUIS//HEMOPLASMA
10 0.0000004775 ETS 1//PU1//HEMANGIOBLAST